P
Psilera
Biotech & Life Sciences · Tampa, United States · Founded 2019
Creating new drugs using a proprietary in-house drug discovery engine MoreLess
Psilera is a biotechnology research company founded in 2019, with offices in New Jersey and Florida. The company is led by scientists and co-founded by women, focusing on developing next-generation medicines. Psilera specializes in creating and developing serotonergic compounds, which are chemicals that affect serotonin levels in the brain. These compounds have the potential to treat long-term cognitive diseases and improve the quality of life for patients.
The company operates in the pharmaceutical and biotechnology market, targeting clients such as medical researchers, pharmaceutical companies, and healthcare providers. Psilera's business model revolves around research and development (R&D) of novel compounds, securing patents, and collaborating with academic institutions. They have already filed 13 patents, with two issued, covering over 1 million unique compounds. This intellectual property can be licensed to pharmaceutical companies or used to develop new drugs, generating revenue.
Psilera's approach is rooted in the potential of natural medicines, including psychedelics, to address neurological diseases. They collaborate with scientific experts, such as Katie DeMarsh from the Medical College of Wisconsin, to advance their research. The company aims to unlock the power of these next-generation medicines to change how scientists and doctors view and treat the human mind.
In summary, Psilera is a pioneering biotech firm focused on developing innovative serotonergic compounds to treat cognitive diseases, leveraging a strong patent portfolio and scientific collaborations to drive its business.
Keywords: biotechnology, serotonergic compounds, patents, psychedelics, cognitive diseases, pharmaceutical, research, development, natural medicines, healthcare.
Company overview
Psilera company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2019
- Headquarters
- Tampa, United States
- Employees
- 14
- Open positions
- None listed
- Dealroom signal
- 71.8
Valuation & funding
Psilera funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEED✓Equity / VC | May 2026 | $8.8M | $35M | Undisclosed | ↗ |
| GRANT✓Other financing | Oct 2025 | $2M | — | National Institutes of Health | ↗ |
| SEED✓Equity / VC | Sep 2024 | $200K | $800K | University of South Florida | ↗ |
| OtherOther financing | Nov 2022 | $0 | — | Undisclosed | — |
| GRANTOther financing | Mar 2022 | $130K | — | Undisclosed | — |
| SEED✓Equity / VC | Jul 2021 | Receptor · JLS Fund · What If Ventures · Baird Inc | — | ||
| SPINOUT✓Other financing | Jul 2019 | University of South Florida | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 14 |
| 2025 | 14 |
| 2024 | 12 |
| 2023 | 8 |
Growth signals
Psilera website traffic
Latest recorded traffic for Psilera is 2.1K monthly website visits, up 133.3% over the last three months. Psilera's team grew 0% over the past year.
Comparisons
Psilera compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Psilera's talent
Source: Dealroom Talent Intelligence.
Investors
7 investors on Psilera's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Psilera has talent and traffic
team presence
In the news
Latest news about Psilera
Recent press, funding announcements, and product moves mentioning Psilera — open to read from the original sources.
Market sentiment
What the market is saying about Psilera
An AI-synthesized read of the highest-engagement posts about Psilera on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Psilera’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.